Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|90|6|321-326

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.6, 2016-05, pp. : 321-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgery after Preoperative Chemotherapy for Patients with Unresectable Advanced Gastric Cancer

By  

Oncology, Vol. 85, Iss. 4, 2013-10 ,pp. : 241-247

Karger

Access to resources Recommend Favorite

ATP-Based Chemotherapy Response Assay in Patients with Unresectable Gastric Cancer

By  

Oncology, Vol. 73, Iss. 5-6, 2008-06 ,pp. : 439-440

Karger

Access to resources Recommend Favorite

Prospective evaluation of 18F‐fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases

By  

HPB, Vol. 17, Iss. 7, 2015-07 ,pp. : 644-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

How Does Inhibition of the Renin-Angiotensin System Affect the Prognosis of Advanced Gastric Cancer Patients Receiving Platinum-Based Chemotherapy?

By  

Oncology, Vol. 83, Iss. 6, 2012-10 ,pp. : 354-360

Karger

Access to resources Recommend Favorite

Inflammation-Based Prognostic Score Predicts Survival in Patients with Advanced Gastric Cancer Receiving Biweekly Docetaxel and S-1 Combination Chemotherapy

By  

Oncology, Vol. 83, Iss. 4, 2012-08 ,pp. : 183-191

Karger

Access to resources Recommend Favorite